Key Milestone in ACTIVATE Phase 2 Clinical Trial of BIA 28-6156
October 2, 2025
Bial, a biopharma company focused on innovation in neurosciences and rare diseases, has shared updates on its Phase 2 study named ACTIVATE (NCT05819359). This trial